High-concentration monoclonal antibodies (mAbs) are gaining prominence given the compliance and cost advantages.

At CPHI Europe, Angela Vollstedt, global director of Cell & Gene Therapies at Novartis discussed scale up strategies for cell ...

EXTON, PA — West Pharmaceutical Services, Inc. (NYSE: WST) has been recognized with the prestigious Heart of Pharma Award at ...

The Egyptian Drug Authority (EDA) has concluded its participation in activities of CPHI Milan, the premier international ...

Blis Technologies is currently engaged in ongoing negotiations with Bluestone Pharma and Lactosan, following the discovery that Bluestone Pharma had filed patents for Blis' fermentation processes, ...

The winners of this year’s awards showcase achievements in pharma excellence. CPHI announced the winners of the 2024 Pharma Awards on Oct. 8, 2024 at CPHI Milan in Milan, Italy (1). And the winners ...

Pharmaceutical Technology® Europe spoke with Nicolas Camper, senior director—Bioconjugation Chemistry at Abzena during CPHI Milan. Camper discussed the advancements in conjugation and linker ...

Curia Unveils Brand Refresh at CPHI WW in Milan The refined brand highlights Curia’s key capabilities and personalized ...

South Korea's leading contract development and manufacturing organization Samsung Biologics said Monday it will participate ...